{"slideshow_credits": null, "snippet": "A nasal spray designed to reverse opioid overdoses won approval from the Food and Drug Administration, expanding the options for treating drug overdoses without medical training.", "abstract": "Food and Drug Administration approves Narcan nasal spray, created by Adapt Pharma Incto to reverse opioid overdoses; approval expands options for treating overdoses without medical training.", "section_name": "U.S.", "print_page": "20", "document_type": "article", "byline": {"person": [{"firstname": "Sabrina", "role": "reported", "lastname": "TAVERNISE", "rank": 1, "organization": ""}], "original": "By SABRINA TAVERNISE", "contributor": ""}, "web_url": "http://www.nytimes.com/2015/11/19/us/fda-approves-a-nasal-spray-to-combat-opioid-overdose.html", "lead_paragraph": "A nasal spray designed to reverse opioid overdoses won approval from the Food and Drug Administration, expanding the options for treating drug overdoses without medical training.", "headline": {"main": "F.D.A. Approves a Nasal Spray to Combat Opioid Overdose", "content_kicker": "National Briefing | Health", "print_headline": "F.D.A. Approves a Nasal Spray to Combat Opioid Overdose"}, "_id": "564d433638f0d81eb3ced0d7", "word_count": "87", "multimedia": [], "pub_date": "2015-11-19T00:00:00Z", "source": "The New York Times", "news_desk": "National", "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "1"}, {"name": "subject", "value": "Drug Abuse and Traffic", "is_major": "Y", "rank": "2"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Naloxone (Drug)", "is_major": "Y", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "Brief"}